But the phase 2 clinical trial data is what BP moves on for a takeover, right? Or was it the end of phase 1 like you declared recently? I can't keep up.
I might have missed it because I'm not as well versed on IMU as you, but I can't remember getting taken over at the conclusion of the her-vaxx phase 2 trials. Wow, BP must be as blind as me and every other concerned shareholder that wants to see leadership change.
Are we running everything through to phase 3 end now? We'll have to have 40 billion shares on issue for that, and that's assuming the share price doesn't decline from here. Maybe a few more CN/W agreements will get us there.
Maybe I'll put a buy order in at 0.001, can't be too far away.
IMU Price at posting:
3.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)